NMT Medical Presents Migraine Study Data MIST Study

NMT Medical -- a designer, developer and marketer of minimally invasive solutions for the treatment of cardiac sources of migraine headaches, stroke and other potential brain attacks -- announced that data from its MIST (Migraine Intervention with STARFlex Technology) study was reported at the EuroPCR meeting in Paris. Data on the incidence of PFO (patent foramen ovale) observed in the MIST study was presented by Peter Wilmshurst. In the presentation, Wilmshurst said, "In our evaluation of 370 migraine patients, we found that 50 percent of them had a PFO, which allows a right to left shunt, or flow, of venous blood into the arterial circulation."

()a href="http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/05-24-2005/0003685605&EDATE=" target="_blank">PR Newswire